This manuscript provides valuable information about the genesis of CPSF6 condensates due to HIV-1 infection. However, the evidence is incomplete as it is missing more functional assays. Furthermore, ...
Antiretroviral therapy effectively suppresses HIV viral loads to undetectable levels but cannot eliminate the integration of viral DNA into the host cell genome. A novel class of HIV-1 antivirals that ...
Lenacapavir works by targeting the HIV capsid, a protein shell that protects the virus's genetic material. The drug is not a standalone therapy and must be used in combination with other ...
The drug, named lenacapavir, targets the structure and function of HIV's capsid protein. It protects people for 6 months with each shot. Unlike mainstay HIV drugs that disrupt viral enzymes by ...